From discovery to licensure, the Adjuvant System story
Adjuvants are substances added to vaccines to improve their immunogenicity. Used for more than 80 years, aluminum, the first adjuvant in human vaccines, proved insufficient to develop vaccines that could protect against new challenging pathogens such as HIV and malaria. New adjuvants and new combina...
Main Authors: | Nathalie Garçon, Alberta Di Pasquale |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2016.1225635 |
Similar Items
-
Vaccine Adjuvants: from 1920 to 2015 and Beyond
by: Alberta Di Pasquale, et al.
Published: (2015-04-01) -
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
by: Arnaud M. Didierlaurent, et al.
Published: (2017-01-01) -
The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development
by: Michael Kozak, et al.
Published: (2023-03-01) -
Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
by: Daniel Sepulveda-Crespo, et al.
Published: (2020-06-01) -
Inflammasomes as Targets for Adjuvants
by: Konstantin Ivanov, et al.
Published: (2020-03-01)